Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

October 1, 2011

Primary Completion Date

June 1, 2014

Study Completion Date

January 1, 2015

Conditions
Lung CancerTobacco Use DisorderBreast CancerColorectal CancerProstate Cancer
Interventions
DRUG

Nicotine Replacement Patch

Study participants will receive a baseline assessment after they consent to participate and before randomization. The intervention period will last 12 weeks (approximately 1 week for the in-office intervention and 12 weeks for all components of the Quitline intervention- telephone counseling and habitrol patches). Follow-up assessments will be administered at 3, 6, 12, \& 24 weeks after the date of the in-person intervention (for Quitline Intervention group) or the provision of the physician letter (for the Usual Care Plus group).

Trial Locations (1)

27157

W F Baptist Health, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT01434342 - Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients | Biotech Hunter | Biotech Hunter